Method promoting conception by administering IL-8 or MCAF
US6013252A · kind A · utility
4Cited by
4References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 5, 1997 |
| Grant date | Jan 11, 2000 |
| Priority date | — |
| Expiry date | Jun 5, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/217
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Leukocyte chemotactic factors such as interleukin-8 and MCAF, and inductive substances therefor were revealed to have proconceptive activities. These activities include promoting ovum growth and fertilized ovum implantation, and are exhibited by a sole substance. Accordingly, it has been shown that such substances can be used in drugs concerning medical treatment for infertility, and further, can be used in veterinary and livestock industry fields such as reproduction of industrial animals or species preservation of rare animals.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.